Linda Stocum, Associate Editor

At Maui Derm NP+PA Fall 2021, George Martin, MD, discussed his opinion on best treatment options for SCC in situ and cutaneous SCC at high risk for metastasis along with BCC that require special considerations.

A study published in the Journal of Drugs in Dermatology compared the efficacy of natural ingredient-based moisturizing cream versus a colloidal oatmeal moisturizing cream.

A review of the American Academy of Dermatology guidelines and current treatment improvements for actinic keratosis were discussed during a presentation at Maui Derm NP+PA Fall 2021.

As a part of her Maui Derm NP+PA Fall 2021 presentation, Phoebe Rich, MD, discusses how different diseases manifest in the nails, including multiple patient examples, and whether or not biopsy is needed for diagnosis.

The Maui Derm NP+PA Fall 2021 8th Annual Meeting begins today with an in-person, 4-track preconference program at the Omni Grove Park Inn in Asheville, North Carolina. Continue to check in for the next 3 days for the latest coverage of the main program which is from September 30 to October 3.

The new data examines delivery system efficacy of either 1 secukinumab 300-mg dose in an autoinjector vs 2 doses of secukinumab 150-mg 1 mL pre-filled syringes.

R2 Technologies’ Novel Glacial Rx system has been cleared by the FDA for a new indication.

A study published in Molecules explored the vast use of peptides in many therapies that could improve treatments from anti-aging to vaccines.

Zelira Therapeutics has announced the launch of RAF FIVE acne treatment product.

The FDA has announced steps at improving the quality, safety, and efficacy of sunscreens.

Hilary Baldwin, MD, presented on how to recognize, diagnose, and treat rosacea in patients with skin of color at the Skin of Color Update 2021.

Possible melanoma treatments have had multiple newsworthy events since July 2021.

Bristol Myers Squibb has announced that the FDA has accepted the Biologics License Application (BLA) for relatlimab and nivolumab, a fixed-dose combination treatment for unresectable or metastatic melanoma.

Verrica Pharmaceuticals has received a complete response letter from the FDA identifying deficiencies at a manufacturing facility for VP-102.

DermTech’s Pigmented Lesion Assay data was published in SKIN: The Journal of Cutaneous Medicine showing the results of its melanoma detection.

At the 2021 Skin of Color Update, Andrew Alexis, MD, MPH, presented on the subtle distinctions in treating skin of color patients with acne.

ICYMI, some of this week’s featured content includes FDA warnings about JAK inhibitors, and articles about laser treatment for lentigines, Image-Guided Superficial Radiotherapy for BCC and SCC, the risk of insomnia in vitiligo patients, plus more.

The National Rosacea Society has recently released recommendations based on a group discussion regarding updates in rosacea.

Jill Waibel, MD, discusses her recommendations on how to treat keloids and scaring using lasers in her presentation at the Skin of Color Update 2021.

Derm-Biome’s topical compounds have positive results in preclinical trial.

New study data shows positive data for Image-Guided Superficial Radiotherapy (IGSRT) in treating basal cell carcinoma and squamous cell carcinoma.

A recent study delved into how well the 730 nm picosecond-domain laser could treat facial and non-facial lentigines in patients.

Dermavant has announced it has dosed the first patient in its phase 3 trial evaluating tapinarof cream for the treatment of moderate to severe atopic dermatitis.

Hilary Baldwin, MD, presents on keloids in light skin patients, hypopigmentation after treatment, to stitch or not to stitch, and more.

ICYMI, some of this week’s featured content includes what's trending in skincare for September 2021, and articles about pyschodermatology of acne in adolescents, drug related psoriasis, the link between psoriasis and dementia, plus more.

The National Psoriasis Foundation has released new guidance statements after the Centers for Disease Control and Prevention provided new information on COVID-19 vaccine boosters for immunocompromised patients.

A study in the Journal of Cosmetic Dermatology investigated whether fermented pomegranate extracts can protect against oxidative stress and skin aging.

A recently published study compared cognition, MRI-markers, and dementia risk in patients diagnosed with psoriasis vs those without psoriasis.

A survey conducted by Acne Wipeout and OnePoll found that Americans miss out on dating, school, hanging out with friends, and work meetings because of their skin.

A recent phase 3 trial investigated the safety of dupilumab as a treatment for severe atopic dermatitis in pediatric patients ages 6 to 11 years.